EFSD / AstraZeneca Programme: Cellular Plasticity Underlying Type2 Diabetes Research |
EFSD has established this new European Diabetes Research Programme supported by an educational grant from AstraZeneca to stimulate European Research in in Cellular Plasticity Underlying the Pathophysiology of Type 2 Diabetes, and encourage projects aimed at advancing current knowledge of this domain.
To achieve the goals and objectives of this Programme, EFSD invites applications by issuring this "Request for Applicaitons" (RFA), which indicates joint funding as well as areas of research emphasis.
Elegibility: Applications for an EFSD/Sanofi grant are invited from single non-profit institutions or groups of such institutions from Europe or associated countries. The principal investigator and any co-investigators must be employed full-time at a non-profit institution and the study must be performed at their place of work.
While all proposals relevant to this research focus will be considered, those projects studying the effect of GLP-1 or DPP4 inhibition on cellular plasticity underlying the recovery of beta cell function will be particularly welcome. Applications for a grant renewal grant will be accepted on a competitive basis, with the same review process.
Review criteria are as follows:
a. Significance:Does the study address an important problem in keeping with the goals and focus areas of this Programme? If the aims of the application are achieved, how will scientific knowledge be advanced? What will be the effect of the proposed studies on the concepts or methods that drive this field?
b. Approach: Are the conceptual framework, design, methods and analyses adequately developed, well integrated, and appropriate to the aims of the project? Are they supported by preliminary data? Does the applicant acknowledge potential problem areas and consider alternative tactics?
c. Innovation: Does the project employ novel concepts, approaches or methods? Are the aims original and innovative? Does the project challenge existing paradigms or develop new methodologies or technologies?
d. Investigator: Is the investigator appropriately trained and well suited to carry out this work? Is the work proposed appropriate to the experience level of the principal investigator and other researchers, if any?
e. Environment: Does the scientific environment in which the work will be done contribute to the probability of success? Do the proposed experiments take advantage of unique features of the scientific environment or employ useful collaborative arrangements? Is there evidence of institutional support?
f. Budget: Is the requested budget appropriate for the proposed study?
Amount and duration: Research will be supported through the award of grants, each of up to 100,000 €, payable in the first year and in one instalment. The duration of each award may be 1 year or longer, depending upon the needs of the project and as justified in the application.
Internal deadline (VHIR) for applications: 24 October 2014
Official deadline: 1 November 2014
Anticipated award: February 2015
More information: HERE
© FIR-HUVH Fundació Institut de Recerca Hospital Universitari Vall d'Hebron 2014 | Vull rebre informació del VHIR ![]() |
Ajudi’ns a millorar ![]() |
![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |